Publications by authors named "Kim Bridle"

Claim this Profile
A
An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.
Qi Ruan, Tao Chen, Minwoo Kim, Haotian Yang, Debottam Sinha, Kim Bridle

Hepatology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perisurgical colony stimulating factor one treatment ameliorates liver ischaemia/reperfusion injury in rats.
Sarah Schulze, Sahar Keshvari, Gregory C Miller, Kim R Bridle, David A Hume

World J Gastroenterol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers.
Arunpandian Balaji, Craig A Bell, Zachary H Houston, Kim R Bridle, Berit Genz

Biomaterials· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver.
Darrell H G Crawford, Grant A Ramm, Kim R Bridle, Amanda J Nicoll, Martin B Delatycki

Hepatol Int· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: A systematic review and meta-analysis.
Xin Liu, Haolu Wang, Xinyao Liu, Kim Bridle, Darrell Crawford

Pharmacol Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival and postoperative complications of pre-liver transplantation transarterial chemoembolisation in hepatocellular carcinoma: A systematic review and meta-analysis.
Daniel A Butcher, Kelli J Brandis, Haolu Wang, Liam Spannenburg, Kim R Bridle

Eur J Surg Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer.
Lu Cao, Kim R Bridle, Ritu Shrestha, Prashanth Prithviraj, Darrell H G Crawford

Int J Mol Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint molecules are regulated by transforming growth factor (TGF)-1-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
Ritu Shrestha, Kim R Bridle, Darrell H G Crawford, Aparna Jayachandran

Int J Med Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron depletion attenuates steatosis in a mouse model of non-alcoholic fatty liver disease: Role of iron-dependent pathways.
Darrell H G Crawford, Diana G F Ross, Lesley-Anne Jaskowski, Leslie J Burke, Laurence J Britton, Kim R Bridle

Biochim Biophys Acta Mol Basis Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Targeting of Sorafenib-Resistant HCC-Derived Cancer Stem Cells.
Ritu Shrestha, Kim R Bridle, Lu Cao, Darrell H G Crawford, Aparna Jayachandran

Curr Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging-based vascular-related biomarkers for early detection of acetaminophen-induced liver injury.
Haolu Wang, Leslie J Burke, Jatin Patel, Brian Wc Tse, Kim R Bridle

Theranostics· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study.
Lu Cao, Prashanth Prithviraj, Ritu Shrestha, Revati Sharma, Matthew Anaka, Kim R Bridle

J Clin Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Janske Reiling, Nick Butler, Andrew H Simpson, Peter Hodgkinson, Catherine Campbell, Kim J Bridle

Liver Transpl· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Inhibition of TGF-β1-Induced EMT and PD-L1 Silencing Re-Sensitizes Hepatocellular Carcinoma to Sorafenib Treatment.
Ritu Shrestha, Prashanth Prithviraj, Kim R Bridle, Darrell H G Crawford, Aparna Jayachandran

J Clin Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of MLKL Attenuates Necroptotic Cell Death in a Murine Cell Model of Ischaemia Injury.
Raji Baidya, Jérémie Gautheron, Darrell H G Crawford, Haolu Wang, Kim R Bridle

J Clin Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment and Transplantation of Orphan Donor Livers: A Back-to-Base Approach to Normothermic Machine Perfusion.
Janske Reiling, Nick Butler, Andrew Simpson, Peter Hodgkinson, Catherine Campbell, Kim Bridle

Liver Transpl· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Lucas Trevisan França de Lima, Daniel Broszczak, Xi Zhang, Kim Bridle, Darrell Crawford

Biochim Biophys Acta Rev Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma.
Qi Ruan, Haolu Wang, Leslie J Burke, Kim R Bridle, Xinxing Li

Int J Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury.
Raji Baidya, Darrell H G Crawford, Jérémie Gautheron, Haolu Wang, Kim R Bridle

Int J Mol Sci· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF‑α‑mediated epithelial‑to‑mesenchymal transition regulates expression of immune checkpoint molecules in hepatocellular carcinoma.
Ritu Shrestha, Kim R Bridle, Darrell H G Crawford, Aparna Jayachandran

Mol Med Rep· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-33 / Cyclin D1 imbalance in severe liver steatosis predicts susceptibility to ischemia reperfusion injury.
Kelley G Núñez, Anderson Frank, Janet Gonzalez-Rosario, Gretchen Galliano, Kim Bridle

PLoS One· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron Inhibits the Secretion of Apolipoprotein E in Cultured Human Adipocytes.
L J Britton, Kim Bridle, Lesley-Anne Jaskowski, Jingjing He, Choaping Ng

Cell Mol Gastroenterol Hepatol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma.
I-Tao Huang, Bijay Dhungel, Ritu Shrestha, Kim R Bridle, Darrell H G Crawford

Expert Opin Investig Drugs· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma.
Ritu Shrestha, Prashanth Prithviraj, Matthew Anaka, Kim R Bridle, Darrell H G Crawford

Front Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic iron concentration correlates with insulin sensitivity in nonalcoholic fatty liver disease.
Laurence Britton, Kim Bridle, Janske Reiling, Nishreen Santrampurwala, Leesa Wockner

Hepatol Commun· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis